US20090197252A1 - Detection of Mutations - Google Patents
Detection of Mutations Download PDFInfo
- Publication number
- US20090197252A1 US20090197252A1 US11/852,967 US85296707A US2009197252A1 US 20090197252 A1 US20090197252 A1 US 20090197252A1 US 85296707 A US85296707 A US 85296707A US 2009197252 A1 US2009197252 A1 US 2009197252A1
- Authority
- US
- United States
- Prior art keywords
- nucleic acid
- fmo3
- polypeptide
- sequence
- mutation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000035772 mutation Effects 0.000 title claims description 53
- 238000001514 detection method Methods 0.000 title description 6
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 claims abstract description 70
- 150000007523 nucleic acids Chemical group 0.000 claims abstract description 53
- 229920001184 polypeptide Polymers 0.000 claims abstract description 39
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 39
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 39
- 108010057167 dimethylaniline monooxygenase (N-oxide forming) Proteins 0.000 claims abstract description 35
- 241001465754 Metazoa Species 0.000 claims abstract description 34
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 24
- 238000000034 method Methods 0.000 claims abstract description 23
- 102100035041 Dimethylaniline monooxygenase [N-oxide-forming] 3 Human genes 0.000 claims abstract description 22
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 19
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 19
- 239000000796 flavoring agent Substances 0.000 claims description 46
- 108020004414 DNA Proteins 0.000 claims description 23
- 239000000523 sample Substances 0.000 claims description 20
- 101150021564 FMO3 gene Proteins 0.000 claims description 19
- 238000009396 hybridization Methods 0.000 claims description 13
- 108700028369 Alleles Proteins 0.000 claims description 11
- 239000003550 marker Substances 0.000 claims description 11
- 241000251468 Actinopterygii Species 0.000 claims description 8
- 235000013305 food Nutrition 0.000 claims description 8
- 238000012408 PCR amplification Methods 0.000 claims description 6
- 230000004060 metabolic process Effects 0.000 claims description 5
- 108020004711 Nucleic Acid Probes Proteins 0.000 claims description 4
- 230000004075 alteration Effects 0.000 claims description 4
- 230000000295 complement effect Effects 0.000 claims description 4
- 239000002853 nucleic acid probe Substances 0.000 claims description 4
- 239000012634 fragment Substances 0.000 abstract description 13
- 235000013336 milk Nutrition 0.000 description 43
- 239000008267 milk Substances 0.000 description 43
- 210000004080 milk Anatomy 0.000 description 43
- 241000283690 Bos taurus Species 0.000 description 42
- 239000013615 primer Substances 0.000 description 23
- 101100503059 Bos taurus FMO3 gene Proteins 0.000 description 19
- 108020004485 Nonsense Codon Proteins 0.000 description 12
- 230000037434 nonsense mutation Effects 0.000 description 12
- 239000002773 nucleotide Substances 0.000 description 12
- 125000003729 nucleotide group Chemical group 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 241000287828 Gallus gallus Species 0.000 description 10
- 241000282414 Homo sapiens Species 0.000 description 10
- 235000013330 chicken meat Nutrition 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 10
- 108020004999 messenger RNA Proteins 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 238000012163 sequencing technique Methods 0.000 description 10
- 238000009395 breeding Methods 0.000 description 9
- 230000001488 breeding effect Effects 0.000 description 9
- 239000002299 complementary DNA Substances 0.000 description 9
- 244000144980 herd Species 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 238000012175 pyrosequencing Methods 0.000 description 9
- 244000309464 bull Species 0.000 description 8
- 241000282412 Homo Species 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 235000019634 flavors Nutrition 0.000 description 7
- 108020004705 Codon Proteins 0.000 description 6
- 125000003275 alpha amino acid group Chemical group 0.000 description 6
- 239000000969 carrier Substances 0.000 description 6
- 235000013365 dairy product Nutrition 0.000 description 6
- 238000003757 reverse transcription PCR Methods 0.000 description 6
- 238000006467 substitution reaction Methods 0.000 description 6
- 102100035046 Dimethylaniline monooxygenase [N-oxide-forming] 4 Human genes 0.000 description 5
- 101100503061 Homo sapiens FMO3 gene Proteins 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 235000013601 eggs Nutrition 0.000 description 5
- 230000002441 reversible effect Effects 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 108700024394 Exon Proteins 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 238000003205 genotyping method Methods 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 102000054765 polymorphisms of proteins Human genes 0.000 description 4
- 108091026890 Coding region Proteins 0.000 description 3
- 108091092878 Microsatellite Proteins 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 235000020247 cow milk Nutrition 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 238000012217 deletion Methods 0.000 description 3
- 230000037430 deletion Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000006651 lactation Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- 240000002791 Brassica napus Species 0.000 description 2
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- 108020001019 DNA Primers Proteins 0.000 description 2
- 239000003155 DNA primer Substances 0.000 description 2
- 102100032788 Dimethylaniline monooxygenase [N-oxide-forming] 1 Human genes 0.000 description 2
- 102100035047 Flavin-containing monooxygenase 5 Human genes 0.000 description 2
- 101001022794 Homo sapiens Flavin-containing monooxygenase 5 Proteins 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 101100503063 Mus musculus Fmo3 gene Proteins 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 101100503066 Rattus norvegicus Fmo3 gene Proteins 0.000 description 2
- 206010068233 Trimethylaminuria Diseases 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 244000144977 poultry Species 0.000 description 2
- 235000013594 poultry meat Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 235000020185 raw untreated milk Nutrition 0.000 description 2
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- MYHSVHWQEVDFQT-KBHNZSCUSA-N (2R)-2-Hydroxybut-3-enylglucosinolate Chemical compound OC[C@H]1O[C@@H](S\C(C[C@H](O)C=C)=N/OS(O)(=O)=O)[C@H](O)[C@@H](O)[C@@H]1O MYHSVHWQEVDFQT-KBHNZSCUSA-N 0.000 description 1
- 108020005345 3' Untranslated Regions Proteins 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 108020003589 5' Untranslated Regions Proteins 0.000 description 1
- 108091093088 Amplicon Proteins 0.000 description 1
- 244000105975 Antidesma platyphyllum Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 235000019779 Rapeseed Meal Nutrition 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 108091023045 Untranslated Region Proteins 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000007801 affinity label Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 238000007844 allele-specific PCR Methods 0.000 description 1
- 238000012197 amplification kit Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 230000008953 bacterial degradation Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000010805 cDNA synthesis kit Methods 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- -1 compound TMA-oxide Chemical class 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- MYHSVHWQEVDFQT-QQRMYPQYSA-N epi-progoitrin Natural products S(=O)(=O)(O/N=C(\S[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)/C[C@H](O)C=C)O MYHSVHWQEVDFQT-QQRMYPQYSA-N 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 235000009424 haa Nutrition 0.000 description 1
- 238000003988 headspace gas chromatography Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000004777 loss-of-function mutation Effects 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000005528 milk analysis Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000002987 primer (paints) Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- MYHSVHWQEVDFQT-CJVJHIQOSA-N progoitrin Natural products S(=O)(=O)(O/N=C(/S[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)\C[C@@H](O)C=C)O MYHSVHWQEVDFQT-CJVJHIQOSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 239000004456 rapeseed meal Substances 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- HUJXHFRXWWGYQH-UHFFFAOYSA-O sinapine Chemical compound COC1=CC(\C=C\C(=O)OCC[N+](C)(C)C)=CC(OC)=C1O HUJXHFRXWWGYQH-UHFFFAOYSA-O 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
- C12N9/0073—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with NADH or NADPH as one donor, and incorporation of one atom of oxygen 1.14.13
Definitions
- the invention relates to mutations in the flavin-containing monooxygenase (FMO3) gene and methods for detection of such mutations in farm animals and poultry.
- FMO3 flavin-containing monooxygenase
- TMA Trimethylaminuria
- TMA produced is oxidized to the odor- and tasteless compound TMA-oxide by the liver enzyme flavin-containing monooxygenase (FMO) (Hlavica & Kehl, 1977).
- FMO flavin-containing monooxygenase
- the TMA oxide is thereafter excreted in the urine (Al Waiz et al. 1987a).
- the fishy odor is a consequence of impaired oxidation of TMA (Pearson et al. 1979; Spellacy et al. 1979).
- the fishy odor shows a recessive mode of inheritance in human (Al-Walz et al. 1987b, 1987c; Ayesh et al. 1993) whereas in chicken it is described as ‘semidominant’ because the expression has been shown to be dependent on the ingestion of e.g. rapeseed meal (Bolton et al. 1976).
- parents heterozygous for the defect were shown to excrete elevated amounts of TMA in the urine when given oral doses of 600 mg TMA (Al-Waiz et al. 1987c, 1989; Ayesh et al. 1990, 1993).
- TMA e.g. rapeseed meal
- the fishy odor syndrome in humans has recently been shown to be due to mutations in FMO3 encoding an isoform of flavin-containing monooxygenase (Dolphin et al. 1997b; Treacy et al. 1998; Akerman et al. 1999; Basarab et al. 1999; Forrest et al. 2001).
- the gene has been localized to chromosome 1q23-q25 (http://www.ncbi.nlm.nih.gov/LocusLink, August 2001) and its genomic sequence is known (Dolphin et al. 1997a).
- the human FMO3 gene contains one non-coding and 8 coding exons and is 22.5 kb long. (GenBank AH006707, GenBank AL021026)
- TMA Trigger et al. 1982
- TMA Trigger et al. 1982
- progoitrin a substance that in chicken has been shown to act as an FMO inhibitor by competing with TMA for the enzyme's active binding site (Pearson et al. 1982).
- the major source of TMA is marine fish and other seafoods (Zhang et al. 1999).
- FIG. 1 (a) Alignment of codon 236-238 for the normal (R238) and mutant (R238X) FMO3 allele in cattle. This region was analyzed using pyrosequencing. The location of the sequencing primer and the six positions sequenced are indicated. (b) Pyrosequencing results from the three different genotypes at codon 238. The sequenced reverse strand has the sequence (A/G)AGTGA where the A/G polymorphism corresponds to the R238X nonsense mutation.
- the FMO3 nonsense mutation R238X causes fishy off-flavor in milk. This is the first identified gene that has a profound influence on perceived quality of raw milk.
- the genotyping method described in this study can now be used by the breeding organisations to eliminate the problem in those breeds where a FMO3 nonsense mutation is present.
- the present invention provides a polypeptide which is a flavin-containing monooxygenase 3 (FMO3), wherein said FMO3 is a polypeptide comprising at least a sequence having at least 85% identity, preferably at least 90% identity, more preferably at least 95% identity, with the polypeptide sequence SEQ ID NO: 15.
- FMO3 flavin-containing monooxygenase 3
- the present invention further provides polypeptides which are flavin-containing monooxygenase 3 (FMO3), wherein said FMO3 is a polypeptide having at least 85% identity, preferably at least 90% identity, more preferably at least 95% identity, with the polypeptide sequence SEQ ID NO: 15.
- FMO3 flavin-containing monooxygenase 3
- polypeptides of the invention are the bovine FMO3 as shown in SEQ ID NO:15.
- polypeptides of the invention are the sheep and goat FMO3.
- the present invention also provides polypeptides which are functionally altered mutants of flavin-containing monooxygenase 3 (FMO3), wherein said FMO3 is a polypeptide comprising at least a sequence having at least 85% identity, preferably at least 90% identity, more preferably 95% identity, with the polypeptide sequence SEQ ID NO: 15.
- FMO3 flavin-containing monooxygenase 3
- an animal is considered to refer to all animal species, with the exception of humans.
- the present invention is directed towards mutants which result in buildup of TMA resulting in fishy taste and/or smell in an animal.
- mutants includes, but are not limited to, mutants of FMO3 with a decreased catalytic activity towards TMA oxidation.
- Such a functionally altered mutant is a polypeptide resulting from a deletion of a part of the FMO3 polypeptide, such as the R238X variant of the bovine FMO3.
- polypeptides which are functionally altered mutants of flavin-containing monooxygenase 3 (FMO3) according to the invention, may arise from insertions, deletions, and mis-sense mutations in the FMO3 gene.
- FMO3 flavin-containing monooxygenase 3
- the present invention further provides isolated nucleic acid sequences encoding flavin-containing monooxygenase 3 (FMO3), wherein said FMO3 is a polypeptide comprising at least a sequence having at least 85% identity, preferably at least 90% identity, more preferably at least 95% identity, with the polypeptide sequence SEQ ID NO: 15.
- FMO3 flavin-containing monooxygenase 3
- Examples of such isolated nucleic acids are the cDNA sequence encoding the bovine FMO3 shown in SEQ ID NO: 14, the bovine FMO3 gene, or fragments thereof. Examples of such fragments are exons 3, 6, 7 and 9 shown as SEQ ID Nos: 9, 10, 11, and 12, respectively.
- Nucleic acid sequences of the invention include variants of the FMO3 gene, such as the R238X and E287G variants of the bovine FMO3 gene.
- the sequences are aligned for optimal comparison purposes (e.g., gaps can be introduced in the sequence of a first amino acid or nucleic acid sequence for optimal alignment with a second amino or nucleic acid sequence).
- the amino acid residues or nucleotides at corresponding amino acid positions or nucleotide positions are then compared. When a position in the first sequence is occupied by the same amino acid residue or nucleotide as the corresponding position in the second sequence, then the molecules are identical at that position.
- the determination of percent identity between two sequences can be accomplished using a mathematical algorithm.
- a preferred, non-limiting example of a mathematical algorithm utilized for the comparison of two sequences is the algorithm of Karlin and Altschul (1990) Proc. Natl. Acad Sci. USA 87:2264-2268, modified as in Karlin and Altschul (1993) Proc. Natl. Acad. Sci. USA 90:5873. Such an algorithm is incorporated into the NBLAST and XBLAST programs of Altschul, et al. (1990) J. Mol. Biol. 215:403-410.
- Gapped BLAST can be utilized as described in Altschul et al. (1997) Nucleic Acids Res. 25:3389.
- PSI-Blast can be used to perform an iterated search which detects distant relationships between molecules.
- the percent identity between two sequences can be determined using techniques similar to those described above, with or without allowing gaps. In calculating percent identity, only exact matches are counted.
- the invention also includes specific fragments of a nucleic acid sequence of the invention.
- “Specific fragment” refers to a nucleic acids fragment having a sequence that is found only in the nucleic acid sequences of the invention, and is not found in nucleic acid sequences encoding related polypeptides such as FMO1, FMO2, FMO4, and FMO5.
- Such fragments may be, but are not limited to, primers used in amplification reactions such as PCR, or in hybridization experiments.
- Such fragments are therefore typically at least 10 bp in length, such as at least 15 bp, more preferably at least 20 bp, but may also be longer, such as at least 50 bp or at least 100 bp.
- the degree of identity between the different FMOs seems to be the same over the whole sequence, the degree of identity between FMO3 and FMO2 (which is the closest relative) being around 60%.
- the degree of identity between e.g. bovine and human FMO3 is roughly the same over the whole sequence.
- Specifically hybridising fragments refers to nucleic acid fragments which can hybridize, under stringent conditions only with nucleic acids of the invention, without hybridizing with nucleic acid sequences encoding related polypeptides such as FMO1, FMO2, FMO4, and FMO5.
- Said specific fragments or specifically hybridising fragments may for example be used as primers or probes for detecting and/or amplifying nucleic acid sequences encoding FMO3 polypeptides.
- hybridization conditions including stringent conditions. See, e.g., Molecular Cloning: A Laboratory Manual, 3rd ed., Sambrook et al. eds., Cold Spring Harbor Laboratory Press, 2001; DNA Cloning: A practical Approach, Glover & Hames eds., Oxford University Press, 1996; Nucleic Acid Hybridization: Essential techniques, Ross ed. Wiley, 1998.
- stringent hybridization conditions are chosen, by varying the temperature and/or salt concentration in hybridization experiments, such that principally only the molecule of interest hybridizes to the target sequence.
- the invention includes sets of primers comprising at least one primer consisting of a specific fragment or specifically hybridising fragment as defined above.
- mutations in the bovine FMO3 gene may lead to fish off-flavour of milk, caused by an altered metabolism of trimethylamine.
- mutations in the chicken FMO3 gene may be associated with fish off-flavour of eggs produced by hens carrying such mutations.
- the invention also includes a method for detecting a mutation in the FMO3 gene of an animal where the mutation will cause an alteration in the metabolism of trimethylamine leading to a fish off-flavour in a food product of the animal or its offspring
- the food product can be any food product collected or produced from animals or their offspring, such as milk or eggs.
- the animal can be a mammal, excluding humans, used in the production of such food products, such as a cow, a bull, a sheep, or a goat.
- the animal may also be poultry, such as a hen or a cock.
- the method comprises:
- the invention provides a method for detecting a nucleic acid sequence comprising a mutation in the FMO3 gene of an animal where the mutation will cause an alteration in the metabolism of trimethylamine leading to a fish off-flavour in a food product of the animal or its offspring.
- the method comprises:
- the process of the invention further comprises, prior to hybridization, PCR amplification from the nucleic acid sample, of a sequence comprising at least the portion of the FMO3 sequence wherein the mutation is to be detected.
- a mutation in the FMO3 gene may also be detected through detection of polymorphic markers closely linked to said mutation.
- polymorphic markers may be used as surrogate markers for the functional mutation itself, provided that they are in linkage disequilibirum with the mutation.
- the closer the polymorphic marker is to the mutation itself the greater the likelyhood that the marker may be used as surrogate marker.
- the physical distance at which the surrogate marker may be from the mutation is likely to be variable.
- the invention also provides means for identifying said polymorphic markers, and more specifically polymorphic markers comprised within a genomic DNA sequence comprising at least a portion of a FMO3 gene, and up to 500 kb, preferably 300 kb, more preferably up to 100 kb of a 3′ and/or of a 5′ adjacent sequence, or the complement thereof.
- examples of polymorphic markers identified in cDNA sequences from normal alleles from a carrier of the R238X mutation and from a homozygous normal individual are provided.
- Said polymorphic markers may be obtained for instance, by screening a genomic DNA library from an animal with a probe specific for the FMO3 gene, in order to select clones comprising said nucleic acid sequence and flanking genomic sequences, and identifying a polymorphic marker in said flanking genomic sequences.
- the allele(s) of a polymorphic marker associated with a given mutant allele of the FMO3 gene may also easily be identified by use of a genomic DNA library from an individual wherein the presence of said mutant allele has previously been detected by hybridisation with a nucleic acid probe of the invention.
- Polymorphic markers include for instance, single nucleotide polymorphisms (SNP), microsatellites, insertion/deletion polymorphisms and restriction fragment length polymorphisms (RFLP). These polymorphic markers may be identified by comparison of sequences flanking the FMO3 gene obtained from several individuals. Microsatellites may also be identified by hybridisation with a nucleic acid probe specific of known microsatellite motifs using techniques known to those skilled in the art. Once a polymorphic marker has been identified, a DNA segment spanning the polymorphic locus may be sequenced and a set of primers allowing amplification of said DNA segment may be designed. The invention also encompasses said DNA primers. Design and use of DNA primers for the purpose of amplification by PCR or hybridization is within the skill of the person of ordinary skill. Thus, appropriate primers can be selected from the sequences of the invention using methods known to those skilled in the art.
- Detection of a mutation in FMO3 gene may be performed by obtaining a sample of genomic DNA from an animal, amplifying a segment of said DNA spanning a polymorphic marker by PCR using a set of primers of the invention, and detecting in said amplified DNA the presence of an allele of said polymorphic marker associated with said mutation.
- kits for the practice of the methods of the invention.
- a kit comprises at least one specific fragment of a nucleic acid of the invention, or at least one nucleic acid fragment able to hybridise with a nucleic acid sequence of the invention.
- Said nucleic acid may be labelled using techniques known to those skilled in the art. Examples of suitable labels include, but are not limited to, radioactive labels, fluorescent labels and affinity labels such as biotin.
- the kits may also comprise a set of primers of the invention. They may be used in conjunction with commercially available amplification kits. They may also include positive and/or negative control reactions or markers, molecular weight size markers for gel electrophoresis, and the like.
- a preferred embodiment of the invention relates to the identified R238X mutation in the bovine FMO3 and methods to identify the mutation in order to be able to remove that mutation from stock.
- the genotyping methods of the present invention can be used to eliminate the problem in those breeds where a FMO3 nonsense mutation, or other mutations leading to fishy odor or taste, is present.
- a practical way to reduce the problem would be to genotype currently used breeding bulls, bull dams, and young potential breeding bulls before progeny testing, determine which animals are carriers of the mutation(s), and eliminate carriers from breeding. That way, the detrimental mutation(s) can be eliminated from the selected breed.
- the present study included two different groups of dairy cattle.
- the first material comprised 21 cows of the Swedish Red and White breed (SRB) with information from sensory analyses on the milk.
- Ten of the cows belong to either of the two experimental herds, Jälla and Kungsangen, at Swedish University of Agricultural Sciences in Uppsala.
- the remaining cows belong to either of four commercial herds, all of which had received complaints about fishy off-flavor in the bulk milk.
- ‘control’ cows were chosen that were comparable to the affected cows as regards breed, lactation number, and stage of lactation but were producing milk with a normal taste and smell.
- a population study was performed in which bulls and cows from the four dairy breeds in Sweden were genotyped for the observed FMO3 nonsense mutation. From each of the two major breeds, SRB and Swedish Holstein, 100 individuals were chosen, whereas from the two small breeds, Swedish Polled and Swedish Jersey, 25 and 23 individuals were sampled, respectively. Genomic DNA was prepared from blood samples according to standard protocols.
- Exonic parts of the FMO3 gene were amplified from genomic DNA samples using primers corresponding to sequences well conserved between the human, rabbit, mouse, and rat FMO3 sequences available in GenBank (Table 1). Two genomic DNA samples were used, one from a cow that had been shown to repeatedly produce milk with a fishy flavor and the other from a control cow producing normal milk.
- the PCR was performed in 10 ⁇ l reactions including 1 ⁇ PCR buffer, 1.5 mM MgCl 2 , 0.2 mM of each dNTP, 2.5 pmol of each primer, 25 ng genomic DNA, and 0.35 U AmpliTaq DNA polymerase (Perkin Elmer, Branchburg, N.J., USA).
- Thermocycling was carried out in a PTC200 machine (MJ Research, Watertown, Mass., USA) and included 40 cycles with annealing at 53° C. for 30 s and extension at 72° C. for 2 min.
- the denaturation step was 95° C. for 1-2 min in the first two cycles, and 94° C. for 30 s in the remaining cycles.
- the products were analyzed by agarose gel electrophoresis (4% Nusieve/Seakem 3:1, FMC Bioproducts, Rockland, Me., USA).
- the PCR products were directly sequenced with BigDye terminators and an ABI377 instrument (Perkin-Elmer, Foster City, Calif., USA). Sequence analysis and comparison of sequences from the cows with fishy flavored and normal milk, respectively, was performed using the Sequencher software (GENE CODES, Ann Arbor, Mich., USA).
- Bovine FMO3 sequences corresponding to human FMO3 exons 3, 6, 7, 9, and intron 8 were generated and are given in SEQ ID Nos: 9-13. Subsequently, the complete coding region of the bovine FMO3 gene was sequenced from RT-PCR products from liver mRNA. The bovine FMO3 cDNA sequence is given in SEQ ID NO: 14 and the corresponding polypeptide sequence of bovine FMO3 is given in SEQ ID NO: 15. The exonic sequences generated from genomic DNA showed 100% identity to the cDNA sequence obtained from the RT-PCR products and FMO3 specificity was strongly supported by the high sequence similarity to other mammalian FMO3 sequences. For example, a Blast comparison between the complete coding cattle FMO3 sequence obtained here and the corresponding human sequence (GenBank NM — 006894) showed 85% and 82% identity at the nucleotide and amino acid levels, respectively.
- Partial cattle FMO3 sequences obtained from a cow producing milk with strong fishy off-flavor and a cow producing normal milk were compared.
- the coding part includes 268 codons, corresponding to approximately 50% of the protein.
- the only sequence difference found between the two cows was a C/T nucleotide substitution located at position 62 in exon 6 (SEQ ID NO: 10).
- the C/T substitution changes the codon for arginine (R) at position 238 to a stop codon (X); the numbering of amino acid positions are based on the human amino acid sequence given in Genbank NM — 006894. This nonsense mutation is thus denoted R238X.
- the pyrosequencing test confirmed that the affected cow was homozygous for the R238X substitution whereas the control cow was homozygous R/R at residue 238 ( FIG. 1 ).
- SNP single nucleotide polymorphism
- exon 6 was genotyped by pyrosequencing (Ronaghi et al. 1998) using a Luc96 instrument (Pyrosequencing AB, Uppsala, Sweden). This included PCR amplification of a 147 bp product from genomic DNA samples using the forward primer 5′-biotin-GAT GAA GGC TAT CCA TGG GAC (SEQ ID NO: 16) and the reverse primer 5′-TAA AGG CAT CAA GCC GTA GTT CTC (SEQ ID NO: 17). The PCR was performed in 20 ⁇ l reactions with concentrations of reagents as above.
- Thermocycling was carried out in a PE9600 instrument (Perkin-Elmer, Foster City, Calif., USA) and included an initial denaturation step at 94° C. for 2 min followed by 5 cycles with 94° C. for 30 s, 55° C. for 30 s, 72° C. for 45 s, 43 cycles with 94° C. for 20 s, 50° C. for 30 s, 72° C. for 45 s, and a final extension step at 72° C. for 5 min. Pyrosequencing on the forward strand was done using the reverse sequencing primer 5′ TGA GGA ATG TTT CAA ATC (SEQ ID NO: 18) and conditions according to the manufacturer's recommendations.
- livers from SRB cattle were collected and the pyrosequencing test showed that two were heterozygous carriers of the R238X mutation.
- One of these livers as well as one liver from a homozygous wild-type cow were used for mRNA preparation, reverse transcription (RT)-PCR amplification and direct sequencing of the coding FMO3 region.
- RT reverse transcription
- Two additional primers were used for this purpose, designed from sequences in the untranslated regions which showed conservation between other mammalian FMO3 sequences.
- the 5′UTR primer 5′ GGA CTT AGA CAC ACA GAA GAA AAG AAG (SEQ ID NO: 19) and the 3′UTR primer 5′ GAG GTG TGA AAT TCT TAT TTT TTA AAT AG (SEQ ID NO: 20) were used in pairs with the reverse and forward pyrosequencing PCR primers, respectively.
- the coding sequence was amplified in two overlapping pieces, each including the site of the R238X mutation.
- Poly A mRNA was isolated from cattle livers using the Quickprep mRNA Micro purification kit (Amersham Pharmacia Biotech, Uppsala, Sweden) and RT-PCR was carried out using the First strand cDNA synthesis kit (Amersham Pharmacia Biotech) with ⁇ 200 ng mRNA primed with 0.1 ⁇ g random hexamers in a 15 ⁇ l reaction volume. Two ⁇ l of the completed first strand reaction was used in each PCR reaction with a total volume of 12 ⁇ l so that the final concentrations of dNTP, Mg 2+ , primers, and AmpliTaq polymerase were the same as above. The thermocycling conditions were as described above for the sequenced genomic DNA amplicons but the 5′ part of the cDNA required a repeated PCR to yield enough product for sequencing.
- the pyrosequencing test was used to test a case-control material comprising animals producing milk classified as having a fishy off-flavor and control animals from the same herds (Table 2).
- a Class 2 score means that two trained persons both classified the sample as having a strong fishy off-flavor whereas Class 1 implies that the two persons judged the fishy off-flavor as strong/moderate, moderate/moderate or moderate/normal.
- the results revealed a very strong association between the FMO3 R238X nonsense mutation and strong fishy-off flavor since eight out of nine animals with the Class 2 score were homozygous for this mutation and the ninth was heterozygous. In contrast, the five control samples were homozygous normal.
- the Class 1 group contained animals of all three genotype classes.
- the population screening involved 248 animals representing the four dairy breeds in Sweden.
- the R238X substitution was not found in Swedish Holstein, Swedish Polled, or Swedish Jersey but was surprisingly common in the Swedish Red and White breed (Table 2).
- Two homozygous mutant and 27 heterozygotes were observed among 100 animals and the allele frequency estimate for the mutation was as high as 15.5%.
- the R238X mutation causes a premature termination eliminating more than 50% of the FMO3 enzyme which is expected to comprise 532 amino acids as in the human FMO3 protein. Similar nonsense mutations in humans (E305X, E314X) have been shown to lead to a complete loss of enzyme activity (Treacy et al. 1998, Akerman et al. 1999). Moreover, we observed only barely detectable levels of the mutant transcript in liver mRNA from two heterozygous carriers of R238X. This is most probably explained by nonsense-mediated mRNA decay (NMD; Culbertson 1999). It is very likely that cows homozygous for the R238X mutation show a complete lack of FMO3 activity necessary for the oxidation of TMA to an odorless compound.
- the TMA concentration in the milk from one of the homozygous mutants was shown to vary between 1 and 16 mg TMA/kg milk within a single lactation.
- the sensory evaluation is a somewhat subjective measure.
- the test panel consisting of two trained persons goes through a considerable number of milk samples during one day and may have some difficulties to discern the various off-flavors present in the milk samples and also to discriminate between different flavors.
- the mutation was only observed among the SRB animals, but at a relatively high frequency. This is in complete accordance with the experiences made by the staff at the milk analysis laboratory that performed the sensory analysis, who have so far only encountered the fishy off-flavor in milk from SRB cows.
- the results suggest that the mutation has been present in the existing SRB population for a relatively long period of time.
- the origin of the mutation probably dates back at least to the beginning of the last century, judging from the available pedigree information on affected animals.
- the pedigree data indicate that the mutation may exist in other cattle populations closely related to the Ayrshire.
- Exonic parts of the chicken FMO3 gene will be amplified from genomic DNA samples using both primers corresponding to sequences well conserved between the bovine, human, rabbit, mouse, and rat FMO3 sequences as well as primers corresponding to EST sequences derived from the chicken FMO3 gene, ESTs 603149708F1 and 603610105F1 available in the Chicken EST database (http://www.chick.umist.ac.uk/cgi-bin/chicken_database.cgi). Both genomic DNA samples from hens that have been shown to produce eggs with a fishy off-flavor and genomic DNA samples from normal hens will be used as templates.
- the sequence of cDNA coding for the chicken FMO3 will be obtained from RT-PCR products from liver mRNA.
- sequences obtained from hens that have been shown to produce eggs with a fishy off-flavor and sequences obtained from normal hens will be compared and sequence variants identified.
- Hens will be genotyped and FMO3 variants associated with production of eggs with fishy off-flavour will be identified.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Confectionery (AREA)
- Road Repair (AREA)
Abstract
Description
- The invention relates to mutations in the flavin-containing monooxygenase (FMO3) gene and methods for detection of such mutations in farm animals and poultry.
- Fishy off-flavor in milk is a quality defect recently observed in bulk milk in Sweden, which causes considerable losses to both milk producers and dairy companies. Statistical data from an investigation made 1999 regarding the occurrence of off-flavor in milk showed that out of roughly 2,100 herds, 115 (i.e. >5%) had received one or more complaints about fishy off-flavor in bulk milk. Altogether, these 115 herds had received 242 complaints about a moderate fishy off-flavor, whereas 18 bulk milk samples were classified as having a pronounced fishy odor/taste. Exact figures on the current prevalence of fishy odor among Swedish dairy cows are difficult to estimate as no routine organoleptic testing on milk from individual cows is performed. However, when random samples of bulk milk from individual farms were judged to have a fishy off-flavor, tests on samples from individual cows were sometimes performed. These tests have shown that the off-flavor most often originates from one or a few cows within a herd. In order to exceed the threshold above which the test panel perceives a fishy off-flavor in the farm bulk milk, a sufficiently high proportion of the total milk must come from affected cows. Consequently, an individual cow with a fishy off-flavor in the milk will go undetected unless she belongs to a fairly small herd. The above figure of 5% is thus likely an underestimate of the problem. To what extent this off-flavor occurs in other countries is not known, as the vast majority do not perform regular tests for off-flavor in bulk milk at the farm level. There are so far no indications that the defect has any fatal effects on traits subjected to natural selection, like calf survival, or traits included in the breeding goal for milk production.
- Fishy off-flavor is characterized by a distinct, unpleasant taste and smell, reminiscent of rotting fish. A fishy smell in milk (Humphriss, 1953; Corfield, 1955) and coffee cream (Eyer et al. 1990) has previously been reported in connection with bacterial degradation of lecithin, choline, and betaine, the latter two being intermediate products in the breakdown of lecithin to trimethylamine (TMA) oxide with TMA as an intermediate compound. A further potential source of fishy taint was related to selective oxidation of butterfat (Swoboda & Peers, 1977). The human nose is extremely sensitive to the TMA odor (Ayesh & Smith, 1990), e.g. the olfactory threshold for detection in milk lies around 1-2 ppm (Metha et al. 1974; von Gunten et al. 1976). As a consequence, milk from a few affected cows in a herd has been shown to be sufficient to cause a fishy off-flavor to the whole bulk milk. There have been a few reports on fishy odor in milk related to TMA content in milk from cows on wheat pasture (Metha et al. 1974; von Gunten et al. 1976; Kim et al. 1980).
- Problems with fishy odor associated with elevated TMA levels have been described in human (‘Fish-odor syndrome’ or ‘Trimethylaminuria’, OMIM #602079, http://www.ncbi.nlm.nih.gov) and chicken (Hobson-Frohock et al. 1973). In human, abnormal secretion of TMA has been observed in breath, urine, sweat, saliva, and vaginal secretions (Humbert et al. 1970), whereas in chicken the TMA has predominantly been found in egg yolk (Hobson-Frohock et al. 1973). The TMA is derived from the intestinal degradation of food/feed components rich in TMA or its precursors. Under normal conditions the TMA produced is oxidized to the odor- and tasteless compound TMA-oxide by the liver enzyme flavin-containing monooxygenase (FMO) (Hlavica & Kehl, 1977). The TMA oxide is thereafter excreted in the urine (Al Waiz et al. 1987a). The fishy odor is a consequence of impaired oxidation of TMA (Pearson et al. 1979; Spellacy et al. 1979).
- The fishy odor shows a recessive mode of inheritance in human (Al-Walz et al. 1987b, 1987c; Ayesh et al. 1993) whereas in chicken it is described as ‘semidominant’ because the expression has been shown to be dependent on the ingestion of e.g. rapeseed meal (Bolton et al. 1976). In human, parents heterozygous for the defect were shown to excrete elevated amounts of TMA in the urine when given oral doses of 600 mg TMA (Al-Waiz et al. 1987c, 1989; Ayesh et al. 1990, 1993). However, in none of the cases did the treatment result in a fishy odor.
- The fishy odor syndrome in humans has recently been shown to be due to mutations in FMO3 encoding an isoform of flavin-containing monooxygenase (Dolphin et al. 1997b; Treacy et al. 1998; Akerman et al. 1999; Basarab et al. 1999; Forrest et al. 2001). The gene has been localized to chromosome 1q23-q25 (http://www.ncbi.nlm.nih.gov/LocusLink, August 2001) and its genomic sequence is known (Dolphin et al. 1997a). The human FMO3 gene contains one non-coding and 8 coding exons and is 22.5 kb long. (GenBank AH006707, GenBank AL021026)
- The elevated concentration of TMA observed in various tissues in human, chicken, and cattle is likely to be due to a combination of genetic and dietary effects. Feed components rich in TMA precursors such as betaine, choline and sinapin, are beet products, green leaves and cereals, and rapeseed products. A high intake of these products may result in an accumulation of TMA, which in turn overloads the enzyme system. Rapeseed also contains progoitrin, a substance that in chicken has been shown to act as an FMO inhibitor by competing with TMA for the enzyme's active binding site (Pearson et al. 1982). In humans, the major source of TMA is marine fish and other seafoods (Zhang et al. 1999).
-
FIG. 1 . (a) Alignment of codon 236-238 for the normal (R238) and mutant (R238X) FMO3 allele in cattle. This region was analyzed using pyrosequencing. The location of the sequencing primer and the six positions sequenced are indicated. (b) Pyrosequencing results from the three different genotypes at codon 238. The sequenced reverse strand has the sequence (A/G)AGTGA where the A/G polymorphism corresponds to the R238X nonsense mutation. - According to the invention it is shown that the FMO3 nonsense mutation R238X causes fishy off-flavor in milk. This is the first identified gene that has a profound influence on perceived quality of raw milk. The genotyping method described in this study can now be used by the breeding organisations to eliminate the problem in those breeds where a FMO3 nonsense mutation is present.
- The present invention provides a polypeptide which is a flavin-containing monooxygenase 3 (FMO3), wherein said FMO3 is a polypeptide comprising at least a sequence having at least 85% identity, preferably at least 90% identity, more preferably at least 95% identity, with the polypeptide sequence SEQ ID NO: 15.
- The present invention further provides polypeptides which are flavin-containing monooxygenase 3 (FMO3), wherein said FMO3 is a polypeptide having at least 85% identity, preferably at least 90% identity, more preferably at least 95% identity, with the polypeptide sequence SEQ ID NO: 15.
- An example of such a polypeptide is the bovine FMO3 as shown in SEQ ID NO:15. Further examples of polypeptides of the invention are the sheep and goat FMO3.
- The present invention also provides polypeptides which are functionally altered mutants of flavin-containing monooxygenase 3 (FMO3), wherein said FMO3 is a polypeptide comprising at least a sequence having at least 85% identity, preferably at least 90% identity, more preferably 95% identity, with the polypeptide sequence SEQ ID NO: 15.
- In the present context, an animal is considered to refer to all animal species, with the exception of humans.
- In a preferred aspect, the present invention is directed towards mutants which result in buildup of TMA resulting in fishy taste and/or smell in an animal. Such mutants includes, but are not limited to, mutants of FMO3 with a decreased catalytic activity towards TMA oxidation.
- An example of such a functionally altered mutant is a polypeptide resulting from a deletion of a part of the FMO3 polypeptide, such as the R238X variant of the bovine FMO3.
- Other examples of polypeptides which are functionally altered mutants of flavin-containing monooxygenase 3 (FMO3) according to the invention, may arise from insertions, deletions, and mis-sense mutations in the FMO3 gene.
- The present invention further provides isolated nucleic acid sequences encoding flavin-containing monooxygenase 3 (FMO3), wherein said FMO3 is a polypeptide comprising at least a sequence having at least 85% identity, preferably at least 90% identity, more preferably at least 95% identity, with the polypeptide sequence SEQ ID NO: 15.
- Examples of such isolated nucleic acids are the cDNA sequence encoding the bovine FMO3 shown in SEQ ID NO: 14, the bovine FMO3 gene, or fragments thereof. Examples of such fragments are exons 3, 6, 7 and 9 shown as SEQ ID Nos: 9, 10, 11, and 12, respectively.
- Nucleic acid sequences of the invention include variants of the FMO3 gene, such as the R238X and E287G variants of the bovine FMO3 gene.
- To determine the percent identity of two amino acid sequences or of two nucleic acids sequences, the sequences are aligned for optimal comparison purposes (e.g., gaps can be introduced in the sequence of a first amino acid or nucleic acid sequence for optimal alignment with a second amino or nucleic acid sequence). The amino acid residues or nucleotides at corresponding amino acid positions or nucleotide positions are then compared. When a position in the first sequence is occupied by the same amino acid residue or nucleotide as the corresponding position in the second sequence, then the molecules are identical at that position. The percent identity between the two sequences is a function of the number of identical positions shared by the sequences (i.e., % identity=# of identical positions/total # of positions (e.g., overlapping positions)×100). In one embodiment the two sequences are the same length.
- The determination of percent identity between two sequences can be accomplished using a mathematical algorithm. A preferred, non-limiting example of a mathematical algorithm utilized for the comparison of two sequences is the algorithm of Karlin and Altschul (1990) Proc. Natl. Acad Sci. USA 87:2264-2268, modified as in Karlin and Altschul (1993) Proc. Natl. Acad. Sci. USA 90:5873. Such an algorithm is incorporated into the NBLAST and XBLAST programs of Altschul, et al. (1990) J. Mol. Biol. 215:403-410. BLAST nucleotide searches can be performed with the NBLAST program, score=100, wordlength=12, to obtain nucleotide sequences homologous to a nucleic acid molecules of the invention. BLAST protein searches can be performed with the XBLAST program, score=50, wordlength=3 to obtain amino acid sequences homologous to a protein molecule of the invention. To obtain gapped alignments for comparison purposes, Gapped BLAST can be utilized as described in Altschul et al. (1997) Nucleic Acids Res. 25:3389. Alternatively, PSI-Blast can be used to perform an iterated search which detects distant relationships between molecules. When utilizing BLAST, Gapped BLAST, and PSI-Blast programs, the default parameters of the respective programs (e.g., XBLAST and NBLAST) can be used. See http://www.ncbi.nlm.nih.gov.
- The percent identity between two sequences can be determined using techniques similar to those described above, with or without allowing gaps. In calculating percent identity, only exact matches are counted.
- The invention also includes specific fragments of a nucleic acid sequence of the invention. “Specific fragment” refers to a nucleic acids fragment having a sequence that is found only in the nucleic acid sequences of the invention, and is not found in nucleic acid sequences encoding related polypeptides such as FMO1, FMO2, FMO4, and FMO5. Such fragments may be, but are not limited to, primers used in amplification reactions such as PCR, or in hybridization experiments. Such fragments are therefore typically at least 10 bp in length, such as at least 15 bp, more preferably at least 20 bp, but may also be longer, such as at least 50 bp or at least 100 bp. The degree of identity between the different FMOs seems to be the same over the whole sequence, the degree of identity between FMO3 and FMO2 (which is the closest relative) being around 60%. The degree of identity between e.g. bovine and human FMO3 is roughly the same over the whole sequence.
- “Specifically hybridising fragments” refers to nucleic acid fragments which can hybridize, under stringent conditions only with nucleic acids of the invention, without hybridizing with nucleic acid sequences encoding related polypeptides such as FMO1, FMO2, FMO4, and FMO5.
- Said specific fragments or specifically hybridising fragments may for example be used as primers or probes for detecting and/or amplifying nucleic acid sequences encoding FMO3 polypeptides.
- Defining appropriate hybridization conditions, including stringent conditions, is within the skill of the art. See, e.g., Molecular Cloning: A Laboratory Manual, 3rd ed., Sambrook et al. eds., Cold Spring Harbor Laboratory Press, 2001; DNA Cloning: A practical Approach, Glover & Hames eds., Oxford University Press, 1996; Nucleic Acid Hybridization: Essential techniques, Ross ed. Wiley, 1998. Thus, stringent hybridization conditions are chosen, by varying the temperature and/or salt concentration in hybridization experiments, such that principally only the molecule of interest hybridizes to the target sequence.
- The invention includes sets of primers comprising at least one primer consisting of a specific fragment or specifically hybridising fragment as defined above.
- As shown herein, mutations in the bovine FMO3 gene may lead to fish off-flavour of milk, caused by an altered metabolism of trimethylamine.
- It is further postulated that mutations in the chicken FMO3 gene may be associated with fish off-flavour of eggs produced by hens carrying such mutations.
- The invention also includes a method for detecting a mutation in the FMO3 gene of an animal where the mutation will cause an alteration in the metabolism of trimethylamine leading to a fish off-flavour in a food product of the animal or its offspring, the food product can be any food product collected or produced from animals or their offspring, such as milk or eggs. The animal can be a mammal, excluding humans, used in the production of such food products, such as a cow, a bull, a sheep, or a goat. The animal may also be poultry, such as a hen or a cock.
- The method comprises:
-
- obtaining a nucleic acid sample from the animal;
- determining the presence in said nucleic acid sample of a nucleic acid sequence encoding a mutated FMO3.
- In yet another embodiment the invention provides a method for detecting a nucleic acid sequence comprising a mutation in the FMO3 gene of an animal where the mutation will cause an alteration in the metabolism of trimethylamine leading to a fish off-flavour in a food product of the animal or its offspring.
- The method comprises:
-
- obtaining a nucleic acid sample from the animal;
- contacting said nucleic acid sample with a nucleic acid probe spanning said mutation under conditions of specific hybridisation between said probe and the mutant sequence to be detected
- detecting the hybridisation complex.
- Preferably, the process of the invention further comprises, prior to hybridization, PCR amplification from the nucleic acid sample, of a sequence comprising at least the portion of the FMO3 sequence wherein the mutation is to be detected.
- Methods allowing the specific hybridisation of a probe only with a perfectly matching complementary sequence, and useful for the detection of punctual mutations are known in the art. They include for instance Allele Specific PCR (Gibbs, Nucleic Acid Res. 17: 2427-2448, 1989), Allele Specific Oligonucleotide Screening (Saiki et al. Nature 324:163-166, 1989).
- A mutation in the FMO3 gene may also be detected through detection of polymorphic markers closely linked to said mutation. Such polymorphic markers may be used as surrogate markers for the functional mutation itself, provided that they are in linkage disequilibirum with the mutation. In general, the closer the polymorphic marker is to the mutation itself, the greater the likelyhood that the marker may be used as surrogate marker. However, due to variations in recombination frequencies throughout the genome, the physical distance at which the surrogate marker may be from the mutation is likely to be variable. The invention also provides means for identifying said polymorphic markers, and more specifically polymorphic markers comprised within a genomic DNA sequence comprising at least a portion of a FMO3 gene, and up to 500 kb, preferably 300 kb, more preferably up to 100 kb of a 3′ and/or of a 5′ adjacent sequence, or the complement thereof. In table 3, examples of polymorphic markers identified in cDNA sequences from normal alleles from a carrier of the R238X mutation and from a homozygous normal individual are provided.
- Said polymorphic markers may be obtained for instance, by screening a genomic DNA library from an animal with a probe specific for the FMO3 gene, in order to select clones comprising said nucleic acid sequence and flanking genomic sequences, and identifying a polymorphic marker in said flanking genomic sequences. The allele(s) of a polymorphic marker associated with a given mutant allele of the FMO3 gene may also easily be identified by use of a genomic DNA library from an individual wherein the presence of said mutant allele has previously been detected by hybridisation with a nucleic acid probe of the invention.
- Polymorphic markers include for instance, single nucleotide polymorphisms (SNP), microsatellites, insertion/deletion polymorphisms and restriction fragment length polymorphisms (RFLP). These polymorphic markers may be identified by comparison of sequences flanking the FMO3 gene obtained from several individuals. Microsatellites may also be identified by hybridisation with a nucleic acid probe specific of known microsatellite motifs using techniques known to those skilled in the art. Once a polymorphic marker has been identified, a DNA segment spanning the polymorphic locus may be sequenced and a set of primers allowing amplification of said DNA segment may be designed. The invention also encompasses said DNA primers. Design and use of DNA primers for the purpose of amplification by PCR or hybridization is within the skill of the person of ordinary skill. Thus, appropriate primers can be selected from the sequences of the invention using methods known to those skilled in the art.
- Detection of a mutation in FMO3 gene may be performed by obtaining a sample of genomic DNA from an animal, amplifying a segment of said DNA spanning a polymorphic marker by PCR using a set of primers of the invention, and detecting in said amplified DNA the presence of an allele of said polymorphic marker associated with said mutation.
- The invention also provides kits for the practice of the methods of the invention. A kit comprises at least one specific fragment of a nucleic acid of the invention, or at least one nucleic acid fragment able to hybridise with a nucleic acid sequence of the invention. Said nucleic acid may be labelled using techniques known to those skilled in the art. Examples of suitable labels include, but are not limited to, radioactive labels, fluorescent labels and affinity labels such as biotin. The kits may also comprise a set of primers of the invention. They may be used in conjunction with commercially available amplification kits. They may also include positive and/or negative control reactions or markers, molecular weight size markers for gel electrophoresis, and the like.
- A preferred embodiment of the invention relates to the identified R238X mutation in the bovine FMO3 and methods to identify the mutation in order to be able to remove that mutation from stock. The genotyping methods of the present invention can be used to eliminate the problem in those breeds where a FMO3 nonsense mutation, or other mutations leading to fishy odor or taste, is present. A practical way to reduce the problem would be to genotype currently used breeding bulls, bull dams, and young potential breeding bulls before progeny testing, determine which animals are carriers of the mutation(s), and eliminate carriers from breeding. That way, the detrimental mutation(s) can be eliminated from the selected breed.
- Realization of the invention can be illustrated by the following examples. These examples should however only be understood as examples of specific embodiments of the present invention, and in no way limiting for its adaptation for other use.
- The present study included two different groups of dairy cattle. The first material comprised 21 cows of the Swedish Red and White breed (SRB) with information from sensory analyses on the milk. Ten of the cows belong to either of the two experimental herds, Jälla and Kungsangen, at Swedish University of Agricultural Sciences in Uppsala. The remaining cows belong to either of four commercial herds, all of which had received complaints about fishy off-flavor in the bulk milk. In three of the six herds, ‘control’ cows were chosen that were comparable to the affected cows as regards breed, lactation number, and stage of lactation but were producing milk with a normal taste and smell.
- A population study was performed in which bulls and cows from the four dairy breeds in Sweden were genotyped for the observed FMO3 nonsense mutation. From each of the two major breeds, SRB and Swedish Holstein, 100 individuals were chosen, whereas from the two small breeds, Swedish Polled and Swedish Jersey, 25 and 23 individuals were sampled, respectively. Genomic DNA was prepared from blood samples according to standard protocols.
- PCR Amplification and Sequencing of the Bovine FMO3 Gene from Genomic DNA Samples
- Exonic parts of the FMO3 gene were amplified from genomic DNA samples using primers corresponding to sequences well conserved between the human, rabbit, mouse, and rat FMO3 sequences available in GenBank (Table 1). Two genomic DNA samples were used, one from a cow that had been shown to repeatedly produce milk with a fishy flavor and the other from a control cow producing normal milk.
-
TABLE 1 Primer sequences used for PCR amplification of the bovine FMO3 gene from genomic DNA. FMO3 region Forward (F) and reverse amplified1 (R) primer sequences 5′-3′exon 3 F: GACCATGCAGAAGAGGGCAG SEQ ID NO: 1 R: CTTAAACTGTATGTATTTCAGGA SEQ ID NO: 2 GGTT exon 6 F: CATCATCAGCTCCAGAAGTGG SEQ ID NO: 3 R: TAAAGGCATCAAGCCATAGTT SEQ ID NO: 4 exon 7 F: CAGAATCCTGAGGAAAGAGCC SEQ ID NO: 5 R: ATTACTTGTGCTGCCCAGCG SEQ ID NO: 6 exon 8-9 F: GATGAATGATATTAATGAGAAAA SEQ ID NO: 7 TGG R: CCGGTCCCACTGGGTCAG SEQ ID NO: 8 1The numbering of exons is based on the described exon-intron organization for the human FMO3 gene (Dolphin et al. 1997a). - The PCR was performed in 10 μl reactions including 1×PCR buffer, 1.5 mM MgCl2, 0.2 mM of each dNTP, 2.5 pmol of each primer, 25 ng genomic DNA, and 0.35 U AmpliTaq DNA polymerase (Perkin Elmer, Branchburg, N.J., USA). Thermocycling was carried out in a PTC200 machine (MJ Research, Watertown, Mass., USA) and included 40 cycles with annealing at 53° C. for 30 s and extension at 72° C. for 2 min. The denaturation step was 95° C. for 1-2 min in the first two cycles, and 94° C. for 30 s in the remaining cycles. The products were analyzed by agarose gel electrophoresis (4% Nusieve/Seakem 3:1, FMC Bioproducts, Rockland, Me., USA). The PCR products were directly sequenced with BigDye terminators and an ABI377 instrument (Perkin-Elmer, Foster City, Calif., USA). Sequence analysis and comparison of sequences from the cows with fishy flavored and normal milk, respectively, was performed using the Sequencher software (GENE CODES, Ann Arbor, Mich., USA).
- Bovine FMO3 sequences corresponding to human FMO3 exons 3, 6, 7, 9, and intron 8 were generated and are given in SEQ ID Nos: 9-13. Subsequently, the complete coding region of the bovine FMO3 gene was sequenced from RT-PCR products from liver mRNA. The bovine FMO3 cDNA sequence is given in SEQ ID NO: 14 and the corresponding polypeptide sequence of bovine FMO3 is given in SEQ ID NO: 15. The exonic sequences generated from genomic DNA showed 100% identity to the cDNA sequence obtained from the RT-PCR products and FMO3 specificity was strongly supported by the high sequence similarity to other mammalian FMO3 sequences. For example, a Blast comparison between the complete coding cattle FMO3 sequence obtained here and the corresponding human sequence (GenBank NM—006894) showed 85% and 82% identity at the nucleotide and amino acid levels, respectively.
- Partial cattle FMO3 sequences obtained from a cow producing milk with strong fishy off-flavor and a cow producing normal milk were compared. The compared sequences included altogether 1522 bp and 808 bp of these represent coding sequence. The coding part includes 268 codons, corresponding to approximately 50% of the protein. The only sequence difference found between the two cows was a C/T nucleotide substitution located at position 62 in exon 6 (SEQ ID NO: 10). The C/T substitution changes the codon for arginine (R) at position 238 to a stop codon (X); the numbering of amino acid positions are based on the human amino acid sequence given in Genbank NM—006894. This nonsense mutation is thus denoted R238X. The pyrosequencing test confirmed that the affected cow was homozygous for the R238X substitution whereas the control cow was homozygous R/R at residue 238 (
FIG. 1 ). - The identified single nucleotide polymorphism (SNP) in exon 6 was genotyped by pyrosequencing (Ronaghi et al. 1998) using a Luc96 instrument (Pyrosequencing AB, Uppsala, Sweden). This included PCR amplification of a 147 bp product from genomic DNA samples using the
forward primer 5′-biotin-GAT GAA GGC TAT CCA TGG GAC (SEQ ID NO: 16) and thereverse primer 5′-TAA AGG CAT CAA GCC GTA GTT CTC (SEQ ID NO: 17). The PCR was performed in 20 μl reactions with concentrations of reagents as above. Thermocycling was carried out in a PE9600 instrument (Perkin-Elmer, Foster City, Calif., USA) and included an initial denaturation step at 94° C. for 2 min followed by 5 cycles with 94° C. for 30 s, 55° C. for 30 s, 72° C. for 45 s, 43 cycles with 94° C. for 20 s, 50° C. for 30 s, 72° C. for 45 s, and a final extension step at 72° C. for 5 min. Pyrosequencing on the forward strand was done using thereverse sequencing primer 5′ TGA GGA ATG TTT CAA ATC (SEQ ID NO: 18) and conditions according to the manufacturer's recommendations. - RT-PCR Amplification and Sequencing of the Bovine FMO3 cDNA
- Ten livers from SRB cattle were collected and the pyrosequencing test showed that two were heterozygous carriers of the R238X mutation. One of these livers as well as one liver from a homozygous wild-type cow were used for mRNA preparation, reverse transcription (RT)-PCR amplification and direct sequencing of the coding FMO3 region. Two additional primers were used for this purpose, designed from sequences in the untranslated regions which showed conservation between other mammalian FMO3 sequences. Thus, the 5′
UTR primer 5′ GGA CTT AGA CAC ACA GAA GAA AAG AAG (SEQ ID NO: 19) and the 3′UTR primer 5′ GAG GTG TGA AAT TCT TAT TTT TTA AAT AG (SEQ ID NO: 20) were used in pairs with the reverse and forward pyrosequencing PCR primers, respectively. Thus, the coding sequence was amplified in two overlapping pieces, each including the site of the R238X mutation. Poly A mRNA was isolated from cattle livers using the Quickprep mRNA Micro purification kit (Amersham Pharmacia Biotech, Uppsala, Sweden) and RT-PCR was carried out using the First strand cDNA synthesis kit (Amersham Pharmacia Biotech) with ˜200 ng mRNA primed with 0.1 μg random hexamers in a 15 μl reaction volume. Two μl of the completed first strand reaction was used in each PCR reaction with a total volume of 12 μl so that the final concentrations of dNTP, Mg2+, primers, and AmpliTaq polymerase were the same as above. The thermocycling conditions were as described above for the sequenced genomic DNA amplicons but the 5′ part of the cDNA required a repeated PCR to yield enough product for sequencing. - The R238X Substitution is Closely Associated with the Presence of Fishy Off-Flavor in Cow's Milk
- The pyrosequencing test was used to test a case-control material comprising animals producing milk classified as having a fishy off-flavor and control animals from the same herds (Table 2). A Class 2 score means that two trained persons both classified the sample as having a strong fishy off-flavor whereas Class 1 implies that the two persons judged the fishy off-flavor as strong/moderate, moderate/moderate or moderate/normal. The results revealed a very strong association between the FMO3 R238X nonsense mutation and strong fishy-off flavor since eight out of nine animals with the Class 2 score were homozygous for this mutation and the ninth was heterozygous. In contrast, the five control samples were homozygous normal. The Class 1 group contained animals of all three genotype classes.
-
TABLE 2 FMO3 genotype distributions in a group of 21 Swedish Red and White cows with or without fishy off-flavor in milk and in animals representing the four different dairy breeds in Sweden FMO3 genotype at codon 238 R/R R/X X/X Total Case/control study Sensor/evaluation:1 Normal 5 0 0 5 Class 1 3 3 1 7 Class 2 0 1 8 9 Population study Breed: Swedish Red and White 71 27 2 100 Swedish Holstein 100 0 0 100 Swedish Polled 25 0 0 25 Swedish Jersey 23 0 0 23 1Evaluation based on two trained persons. Class 2 = both person recognized a strong off-flavor (strong/strong); Class 1 = strong/moderate, moderate/moderate, moderate/normal. - The population screening involved 248 animals representing the four dairy breeds in Sweden. The R238X substitution was not found in Swedish Holstein, Swedish Polled, or Swedish Jersey but was surprisingly common in the Swedish Red and White breed (Table 2). Two homozygous mutant and 27 heterozygotes were observed among 100 animals and the allele frequency estimate for the mutation was as high as 15.5%.
- SNPs Observed by cDNA Sequencing of a Heterozygous R238X Carrier and a Homozygous Normal Animal
- Only the wild type transcript appeared well represented in the mRNA sample from the R238X carrier. Only a very weak sequencing signal could be observed from the mutant transcript, at least 10 times weaker than from the wild type transcript. A similar result was obtained using liver mRNA from a second heterozygous R238X carrier. Consequently, we could not search for possible additional mutations present in the FMO3 allele associated with fishy-off flavour. However, the RT-PCR experiment confirmed that the R238X mutation occurs in an expressed FMO3 gene.
- The comparison of the full-length liver cDNA sequence from the normal allele from the carrier and from the homozygous normal individual revealed three additional single nucleotide polymorphisms (SNPs), all compiled in Table 3. Only one of the SNPs altered the amino acid sequence, E287G.
- The present study has provided compelling evidence for that the observed FMO3 nonsense mutation R238X causes fishy off-flavor in milk. This conclusion is based on (i) the identification of an obvious loss-of-function mutation in a gene associated with a similar syndrome in humans, (ii) a very strong association between the presence of this mutation and a strong fishy-off flavor in a case/control material and finally (iii) the presence of this mutation in the only breed (SRB) tested with well documented cases of a fishy off-flavor.
- The R238X mutation causes a premature termination eliminating more than 50% of the FMO3 enzyme which is expected to comprise 532 amino acids as in the human FMO3 protein. Similar nonsense mutations in humans (E305X, E314X) have been shown to lead to a complete loss of enzyme activity (Treacy et al. 1998, Akerman et al. 1999). Moreover, we observed only barely detectable levels of the mutant transcript in liver mRNA from two heterozygous carriers of R238X. This is most probably explained by nonsense-mediated mRNA decay (NMD; Culbertson 1999). It is very likely that cows homozygous for the R238X mutation show a complete lack of FMO3 activity necessary for the oxidation of TMA to an odorless compound. This provides a plausible explanation for the fishy off-flavor of the milk from these cows. Milk samples from five of the cows homozygous for the mutation and included in this study have previously been analyzed for TMA content using dynamic headspace gas chromatography. The results showed that these milk samples all had comparatively high concentrations of TMA whereas the milk from normal cows showed non-detectable or, in a few cases, very low TMA concentrations.
- The results suggested a recessive mode of inheritance for the fishy-off flavor in cows milk in agreement with the recessive inheritance of the fishy-odor syndrome in humans. However, there was not a perfect agreement between this model and the observations from the case/control study since one carrier was scored as having strong fishy off-flavor (Class 2) and one homozygous mutant showed a moderate off-flavor (Class 1). We think there are two potential explanations from this deviation from a strict recessive model. The fishy-off flavor is influenced by environmental factors, like the presence of TMA precursors or FMO inhibitors in the feed. For example, the TMA concentration in the milk from one of the homozygous mutants was shown to vary between 1 and 16 mg TMA/kg milk within a single lactation. Secondly, the sensory evaluation is a somewhat subjective measure. The test panel consisting of two trained persons goes through a considerable number of milk samples during one day and may have some difficulties to discern the various off-flavors present in the milk samples and also to discriminate between different flavors.
- In the present material the mutation was only observed among the SRB animals, but at a relatively high frequency. This is in complete accordance with the experiences made by the staff at the milk analysis laboratory that performed the sensory analysis, who have so far only encountered the fishy off-flavor in milk from SRB cows. We analyzed the pedigree data for all carriers and homozygous mutants but we did not find any common ancestor of these animals within the last 10 generations. The results suggest that the mutation has been present in the existing SRB population for a relatively long period of time. The origin of the mutation probably dates back at least to the beginning of the last century, judging from the available pedigree information on affected animals. Moreover, the pedigree data indicate that the mutation may exist in other cattle populations closely related to the Ayrshire.
- To the best of our knowledge, this is the first identified gene that has a profound influence on perceived quality of raw milk. The genotyping method described in this study can now be used by the breeding organisations to eliminate the problem in those breeds where a FMO3 nonsense mutation is present. A practical way to reduce the problem would be to genotype currently used breeding bulls, bull dams, and young potential breeding bulls before progeny testing and eliminate carriers from breeding.
- Exonic parts of the chicken FMO3 gene will be amplified from genomic DNA samples using both primers corresponding to sequences well conserved between the bovine, human, rabbit, mouse, and rat FMO3 sequences as well as primers corresponding to EST sequences derived from the chicken FMO3 gene, ESTs 603149708F1 and 603610105F1 available in the Chicken EST database (http://www.chick.umist.ac.uk/cgi-bin/chicken_database.cgi). Both genomic DNA samples from hens that have been shown to produce eggs with a fishy off-flavor and genomic DNA samples from normal hens will be used as templates. The sequence of cDNA coding for the chicken FMO3 will be obtained from RT-PCR products from liver mRNA.
- The sequences obtained from hens that have been shown to produce eggs with a fishy off-flavor and sequences obtained from normal hens will be compared and sequence variants identified.
- Hens will be genotyped and FMO3 variants associated with production of eggs with fishy off-flavour will be identified.
-
- Akerman, B. R., Forrest, S., Chow, L., Youil, R., Knight, M. & Treacy, E. P. 1999. Two novel mutations of the FMO3 gene in a proband with trimethylaminuria. Human Mutation 13:376-379
- Al-Waiz, M., Mitchell, S. C., Idle, J. R. & Smith, R. L. 1987a. The metabolism of 14C-labelled trimethylamine and its N-oxide in man. Xenobiotica 17:551-558
- Al-Waiz, M., Ayesh, R., Mitchell, S. C., Idle, J. R. & Smith, R. L. 1987 b. Trimethylaminuria (fish-odour syndrome)—An inborn error of oxidative metabolism. The Lancet 8533:634-635
- Al-Waiz, M., Ayesh, R., Mitchell, S. C., Idle, J. R. & Smith, R. L. 1987c A genetic polymorphism of the N-oxidation of trimethylamine in humans. Clinical Pharmacology and Therapeutics 42:588-594
- Al-Waiz, M., Ayesh, R., Mitchell, S. C., Idle, J. R. & Smith, R. L. 1989. Trimethylaminuria: the detection of carriers using a trimethylamine load test. Journal of Inherited Metabolic Disease 12:80-85
- Ayesh, R. & Smith, R. L. 1990. Genetic polymorphism of trimethylamine oxidation. Pharmacology & Therapeutics 45:387-401
- Ayesh, R., Mitchell, S. C., Zhang, A. & Smith, R. L. 1993. The fish odour syndrome: biological, familial, and clinical aspects. British Medical Journal 307: 655-657
- Basarab, T. B., Ashton, G. H. S., Menage, H. duP. & McGrath, J. A. 1999. Sequence variation in the flavin-containing mono-oxygenase 3 gene (FMO3) in fish odour syndrome. British Journal of Dermatology 140: 164-167
- Bolton, W., Carter, T. C. & Morley Jones, R. 1976. The hen's egg: Genetics of taints in eggs from hens fed on rapeseed meal. British Poultry Science 17: 313-320
- Corfield, A. 1955. Bacterial fishiness in milk. Dairy Industries December: 1035-1037
- Culbertson, M. R. 1999 RNA surveillance unforeseen consequences for gene expression, inherited genetic disorders and cancer. Trends in Genetics 15:74-80
- Dolphin, C. T., Riley, J. H., Smith, R. L., Shepard, E. A. & Phillips, I. R. 1997 a. Structural organization of the human flavin-containing monooxygenase 3 gene (FMO3), the favoured candidate for fish-odor syndrome, determined directly from genomic DNA. Genomics 46: 260-267
- Dolphin, C. T., Janmohamed, A., Smith, R. L., Shepard, E. A. & Phillips, I. R. 1997b. Missense mutation in flavin-containing mono-oxygenase 3 gene, FMO3, underlies fish-odour syndrome. Nature genetics 17: 491-494
- Eyer, H., Gauch, R. & Bosset, J. O. 1990. Untersuchung des Fehlaromas “fischig” in Kaffeerahm [The fishy off-flavour of coffee cream]. Schweizerische Milchwirtschaftliche Forschung 19:43-45
- Forrest, S. M., Knight, M., Akerman, B. R., Cashman, J. R. & Treacy, E. P. 2001. A novel deletion in the flavin-containing monooxygenase gene (FMO3) in a Greek patient with trimethylaminuria. Pharmacogenetics 11: 169-174
- Hlavica, P. & Kehl, M. 1977. Studies on the mechanism of hepatic microsomal N-oxide formation, the role of cytochrome P-450 and mixed function amine oxidase in the N-oxidation of N,N-dimethylamine. Biochemical Journal 164: 487-496
- Hobson-Frohock, A., Land, D. G., Griffiths, N. M. & Curtis, R. F. 1973. Egg taints: association with trimethylamine. Nature 243: 304-305
- Humbert, J. R., Hammond, K. B., Hathaway, W. E., Marcoux, J. G. & O'Brien, D. 1970. Trimethylaminuria: the fish-odour syndrome. The Lancet 2: 770-771
- Humphriss, E. 1953. Chromogenic bacteria and milk. Dairy Industries September: 781-782
- Kim, H. S., Gilliland, S. E., & Von Gunten, R. L. 1980. Chemical test for detecting wheat pasture flavor in cow's milk. Journal of Dairy Science 63:368-374
- Metha, R. S., Bassette, R. & Ward, G. 1974. Trimethylamine responsible for fishy flavor in milk from cows on wheat pasture. Journal of Dairy Science 57:285-289
- Pearson, A. W., Butler, E. J., Curtis, R. F., Fenwick, G. R., Hobson-Frohock, A. & Land, D. G. 1979. Effect of rapeseed meal on trimethylamine metabolism in the domestic fowl in relation to egg taint. Journal of the Science of Food and Agriculture 30:799-804
- Pearson, A. W., Greenwood, N. M., Butler, E. J. & Fenwick, G. R. 1982. The effects of thionamides and related compounds on trimethylamine oxidase activity in hepatic microsomes isolated from chickens (Gallus domesticus). Comparative Biochemistry and Physiology. C: Comparative Pharmacology 73C: 389-393
- Ronaghi, M., Uhlén, M. & Nyrén, P. 1998. A sequencing method based on real-time pyrophosphate. Science 281: 363, 365.
- Spellacy, E., Watts, R W. E. & Gollamali, S. K. 1979. Trimethylaminuria. Journal of Inherited Metabolic Disease 2: 85-88
- Swoboda, P. A. T., & Peers, K. E. 1977. Volatile odorous compounds responsible for metallic, fishy taint formed in butterfat by selective oxidation. Journal of the Science of Food and Agriculture 28: 1010-1018
- Treacy, E. P., Akerman, B. R., Chow, L. M. L., Youil, R., Bibeau, C., Lin, J., Bruce, A. G., Knight, M., Danks, D. M., Cashman, J. R. & Forrest, S. M. 1998. Mutations of the flavin-containing monooxygenase gene (FMO3) cause trimethylaminuria, a defect in detoxication. Human Molecular Genetics 7: 839-845
- Von Gunten, R. L., Bush, L. J., Odell, G. V., Wells, M. E. & Adams, G. D. 1976. Factors related to the occurrence of trimethylamine in milk. Journal of Milk and Food Technology 39 526-529
- Zhang, A. Q., Mitchell, S. C. & Smith, R. L. 1999. Dietary precursors of trimethylamine in man: a pilot study. Food and Chemical Toxicology 37: 515-520
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/852,967 US20090197252A1 (en) | 2002-01-09 | 2007-09-10 | Detection of Mutations |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200200031 | 2002-01-09 | ||
DKPA200200031 | 2002-01-09 | ||
US10/501,032 US7273703B2 (en) | 2002-01-09 | 2003-01-09 | Detection of mutations |
PCT/IB2003/000028 WO2003057886A2 (en) | 2002-01-09 | 2003-01-09 | Detection of mutations |
US11/852,967 US20090197252A1 (en) | 2002-01-09 | 2007-09-10 | Detection of Mutations |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2003/000028 Continuation WO2003057886A2 (en) | 2002-01-09 | 2003-01-09 | Detection of mutations |
US11/501,032 Continuation US7725996B2 (en) | 2005-08-09 | 2006-08-09 | Method for producing actuator device |
Publications (1)
Publication Number | Publication Date |
---|---|
US20090197252A1 true US20090197252A1 (en) | 2009-08-06 |
Family
ID=8160967
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/501,032 Expired - Lifetime US7273703B2 (en) | 2002-01-09 | 2003-01-09 | Detection of mutations |
US11/852,967 Abandoned US20090197252A1 (en) | 2002-01-09 | 2007-09-10 | Detection of Mutations |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/501,032 Expired - Lifetime US7273703B2 (en) | 2002-01-09 | 2003-01-09 | Detection of mutations |
Country Status (10)
Country | Link |
---|---|
US (2) | US7273703B2 (en) |
EP (1) | EP1470228B1 (en) |
AT (1) | ATE321865T1 (en) |
AU (1) | AU2003201055B2 (en) |
CA (1) | CA2472801C (en) |
DE (1) | DE60304324T2 (en) |
DK (1) | DK1470228T3 (en) |
ES (1) | ES2260624T3 (en) |
NZ (1) | NZ533848A (en) |
WO (1) | WO2003057886A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60304324T2 (en) * | 2002-01-09 | 2006-12-14 | Arexis Ab | MUTATION DETECTION |
EP1518936B1 (en) * | 2003-09-24 | 2007-08-22 | Lohmann Tierzucht GmbH | Marker assisted selection of chicken against fishy taint |
EP1634961A1 (en) * | 2004-09-10 | 2006-03-15 | Hendrix Poultry Breeders B.V. | FMO3 gene polymorphisms |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6762052B1 (en) * | 1993-02-26 | 2004-07-13 | Cashman John R | DNA sequence encoding flavin-containing monooxygenase |
US7273703B2 (en) * | 2002-01-09 | 2007-09-25 | Funbogen Ab | Detection of mutations |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5914329A (en) | 1996-11-26 | 1999-06-22 | Pfizer Inc. | Dimesylate salts of neuropeptide Y ligands |
AU7500800A (en) * | 1999-09-30 | 2001-04-30 | Mcgill University | Human fmo3 gene mutations and polymorphisms, and uses thereof |
-
2003
- 2003-01-09 DE DE60304324T patent/DE60304324T2/en not_active Expired - Lifetime
- 2003-01-09 AT AT03729297T patent/ATE321865T1/en active
- 2003-01-09 US US10/501,032 patent/US7273703B2/en not_active Expired - Lifetime
- 2003-01-09 AU AU2003201055A patent/AU2003201055B2/en not_active Ceased
- 2003-01-09 WO PCT/IB2003/000028 patent/WO2003057886A2/en not_active Application Discontinuation
- 2003-01-09 NZ NZ533848A patent/NZ533848A/en not_active IP Right Cessation
- 2003-01-09 ES ES03729297T patent/ES2260624T3/en not_active Expired - Lifetime
- 2003-01-09 DK DK03729297T patent/DK1470228T3/en active
- 2003-01-09 EP EP03729297A patent/EP1470228B1/en not_active Expired - Lifetime
- 2003-01-09 CA CA2472801A patent/CA2472801C/en not_active Expired - Fee Related
-
2007
- 2007-09-10 US US11/852,967 patent/US20090197252A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6762052B1 (en) * | 1993-02-26 | 2004-07-13 | Cashman John R | DNA sequence encoding flavin-containing monooxygenase |
US7273703B2 (en) * | 2002-01-09 | 2007-09-25 | Funbogen Ab | Detection of mutations |
Also Published As
Publication number | Publication date |
---|---|
US7273703B2 (en) | 2007-09-25 |
US20060147910A1 (en) | 2006-07-06 |
AU2003201055A1 (en) | 2003-07-24 |
WO2003057886A2 (en) | 2003-07-17 |
ATE321865T1 (en) | 2006-04-15 |
CA2472801C (en) | 2011-11-22 |
DK1470228T3 (en) | 2006-07-31 |
ES2260624T3 (en) | 2006-11-01 |
CA2472801A1 (en) | 2003-07-17 |
WO2003057886A3 (en) | 2003-12-18 |
EP1470228B1 (en) | 2006-03-29 |
DE60304324D1 (en) | 2006-05-18 |
NZ533848A (en) | 2006-11-30 |
AU2003201055B2 (en) | 2007-11-29 |
DE60304324T2 (en) | 2006-12-14 |
EP1470228A2 (en) | 2004-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Honkatukia et al. | Fishy taint in chicken eggs is associated with a substitution within a conserved motif of the FMO3 gene | |
US6919177B2 (en) | PRKAG3 alleles and use of the same as genetic markers for reproductive and meat quality traits | |
Lundén et al. | A nonsense mutation in the FMO3 gene underlies fishy off-flavor in cow's milk | |
AU2001288980A1 (en) | Novel PRKAG3 alleles and use of the same as genetic markers for reproductive and meat quality traits | |
Bhuiyan et al. | DNA polymorphisms in SREBF1 and FASN genes affect fatty acid composition in Korean cattle (Hanwoo) | |
US20090197252A1 (en) | Detection of Mutations | |
US20210010023A1 (en) | Use of haplotype of snp site associated with hypoxia tolerance in breeding of megalobrama amblycephala | |
US20080010696A1 (en) | Method of Determining Gene Relating to Favorable Beef Taste and Texture | |
WO2010023407A1 (en) | Genetic markers for meat colour | |
AU2019319547A1 (en) | Methods of detecting inherited myopathies in horses | |
Kale et al. | FASN gene and its role in bovine milk production | |
AU2004213686B2 (en) | Method of evaluating beef taste, texture and so on based on stearoyl-CoA desaturase genotype | |
de la Rúa-Domènech et al. | Equine motor neuron disease is not linked to Cu/Zn superoxide dismutase mutations: sequence analysis of the equine Cu/Zn superoxide dismutase cDNA | |
EP1518936B1 (en) | Marker assisted selection of chicken against fishy taint | |
RU2751959C1 (en) | Method for genetic prediction of beef quality indicators based on additive effect of some snp markers | |
Zhou et al. | Identification of SNPs in ME1 gene and association analysis with meat quality traits in Chinese Red cattle | |
RU2267538C2 (en) | Method for screening animals at increased level of offspring quantity and/or preferable signs of meat quality, protein prkag3 (variants) and protein-coding nucleotide sequence (variants) | |
EP1634961A1 (en) | FMO3 gene polymorphisms | |
CN119391866A (en) | A method for evaluating the corrected milk yield of Chinese Holstein cows | |
CN101481738B (en) | Separated nucleic acid sequence of pork quality trait related gene TRIM54 | |
Pertek | QTL and candidate gene analysis of energy and lipid metabolism in swine | |
GB2455657A (en) | b-carotene 15,15-monooxygenase for genotyping bovine milk for colour or b-carotene content | |
NZ564717A (en) | Marker assisted selection of bovine for desired milk fat colour |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: HENDRIX GENETICS B.V., NETHERLANDS Free format text: LICENSE;ASSIGNOR:FUNBOGARDEN;REEL/FRAME:022078/0419 Effective date: 20080708 |
|
AS | Assignment |
Owner name: HENDRIX GENETICS B.V., NETHERLANDS Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE LICENSE AGREEMENT PREVIOUSLY RECORDED ON REEL 022078 FRAME 0419;ASSIGNOR:FUNBOGEN AB;REEL/FRAME:022408/0795 Effective date: 20080708 |
|
AS | Assignment |
Owner name: FUNBOGEN AB, SWEDEN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:AREXIS AB;REEL/FRAME:031071/0938 Effective date: 20070601 Owner name: AREXIS AB, SWEDEN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LUNDEN, ANNE;ANDERSSON, LEIF;MARKLUND, STEFAN;SIGNING DATES FROM 20041018 TO 20041026;REEL/FRAME:031071/0916 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |